Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Northvale, NJ
SEC filing record 1 source field available
Fiscal year end
31 March
ELITE PHARMACEUTICALS INC /NV/ has filed 1,215 SEC EDGAR filings since 30 Jan 1998

SEC filing history

Showing 226-250 of 753 matching filings.

Per page
25
Current page
10
8-K File 001-15697

FORM 8-K

Filing date
12 Jul 2017
Reporting date
06 Jul 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-15697

FORM 8-K

Filing date
07 Jul 2017
Reporting date
07 Jul 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-15697

FORM 8-K

Filing date
14 Jun 2017
Reporting date
14 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-217866

EFFECT filing

Filing date
05 Jun 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-217866

424B3

Filing date
05 Jun 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
02 Jun 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3/A File 333-217866

FORM S-3/A

Filing date
02 Jun 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
23 May 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-15697

FORM 8-K

Filing date
22 May 2017
Reporting date
17 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-286460

D filing

Filing date
10 May 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-217866

S-3

Filing date
10 May 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 May 2017
Reporting date
28 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-15697

8-K

Filing date
02 May 2017
Reporting date
01 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K/A File 001-15697

8-K/A

Filing date
01 May 2017
Reporting date
28 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-15697

FORM 8-K

Filing date
28 Apr 2017
Reporting date
28 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
27 Feb 2017
Reporting date
23 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
27 Feb 2017
Reporting date
23 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
27 Feb 2017
Reporting date
23 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
27 Feb 2017
Reporting date
23 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
27 Feb 2017
Reporting date
23 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
27 Feb 2017
Reporting date
23 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
27 Feb 2017
Reporting date
23 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-15697

FORM 8-K

Filing date
09 Feb 2017
Reporting date
09 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-212266

424B3

Filing date
09 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .